glp-1 food news Which fast chain's GLP-1-friendly and protein-focused campaign is your favorite? GLP-1 Use and Its Impact
Description
One approach may be to taper off GLP-1s rather than quitting all at once
Your body needs sodium
Insulin signalling and the regulation of glucose and lipid metabolism
The SURMOUNT-5 clinical trial published in The New England Journal of Medicine showed that Zepbound (tirzepatide) achieved an average weight loss of 20.2% compared to 13.7% with Wegovy (semaglutide) at 72 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Inzucchi SE, Bergenstal RM, Buse JB, et al
Shapiro SB, Yin H, Yu OH, Rej S, Suissa S, Azoulay L
